Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion

Experimental Hematology

Volumn 36, Issue 1, 2008, Pages 37-50

  Nakata, Yuji ^a,c   Kondoh, Kensuke ^a,d   Fukushima, Sachiko ^a   Hashiguchi, Akinori ^a   Du, Wenlin ^a   Hayashi, Mutsumi ^a   Fujimoto, Jun ichiroh ^b   Hata, Jun ichi ^a,b   Yamada, Taketo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; D4 GUANINE DIPHOSPHATE DISSOCIATION INHIBITOR; GENE PRODUCT; GUANINE TRIPHOSPHATE; PROTEIN CDC42; RAC PROTEIN; RHO FACTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW; CANCER INVASION; CELL INVASION; CELL MOTILITY; CELL TRANSPLANTATION; CLONING; CONTROLLED STUDY; DEATH; DISSOCIATION INHIBITOR GENE; GENE; GENE ACTIVATION; GENE ACTIVITY; GENE FUNCTION; GENE MUTATION; GENETIC TRANSFECTION; HEMIPLEGIA; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LEUKEMIA CELL; MOUSE; NONHUMAN; PARAPLEGIA; PATHOLOGY; PRIORITY JOURNAL; RAJI CELL; WILD TYPE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BURKITT LYMPHOMA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHILD; CONSERVED SEQUENCE; FEMALE; GENES, DOMINANT; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; GUANOSINE DIPHOSPHATE; HUMANS; LEUKEMIA, T-CELL; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PARESIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RHO GTP-BINDING PROTEINS; SEQUENCE ALIGNMENT; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 37249002893     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.08.023     Document Type: Article

References (52)

1. Fukushima S., Yamada T., Hashiguchi A., Nakata Y., and Hata J. Augmentation of human leukemia cell invasion by the activation of small GTP-binding protein Rho. Exp Hematol 28 (2000) 391-400
2. Hall A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu Rev Cell Biol 10 (1994) 31-54
3. Takai Y., Sasaki T., Tanaka K., and Nakanishi H. Rho as a regulator of the cytoskeleton. Trends Biochem Sci 20 (1995) 227-231
4. Narumiya S. The small GTPase Rho: cellular functions and signal transduction. J Biochem 120 (1996) 215-228
5. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
6. Vojtek A.B., and Cooper J.A. Rho family members: activators of MAP kinase cascades. Cell 82 (1995) 527-529
7. Van Aelst L., and D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 11 (1997) 2295-2322
8. Lelias J.M., Adra C.N., Wulf G.M., et al. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc Natl Acad Sci U S A 90 (1993) 1479-1483
9. Scherle P., Behrens T., and Staudt L.M. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci U S A 90 (1993) 7568-7572
10. Adra C.N., Manor D., Ko J.L., et al. Rho-GDIγ: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc Natl Acad Sci U S A 94 (1997) 4279-4284
11. DerMardirossian C., and Bokoch G.M. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15 (2005) 356-363
12. Hart M.J., Maru Y., Leonard D., Witte O.N., Evans T., and Cerione R.A. A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science 258 (1992) 812-815
13. Chuang T.H., Xu X., Knaus U.G., Hart M.J., and Bokoch G.M. GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein. J Biol Chem 268 (1993) 775-778
14. Takahashi K., Sasaki T., Mammoto A., et al. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 272 (1997) 23371-22375
15. Gorvel J.P., Chang T.C., Boretto J., et al. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity. FEBS Lett 422 (1998) 269-273
16. Golovanov A.P., Chuang T.H., DerMardirossian C., et al. Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol 305 (2001) 121-135
17. Na S., Chuang T.H., Cunningham A., et al. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J Biol Chem 271 (1996) 11209-11213
18. Krieser R.J., and Eastman A. Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis. Cell Death Differ 6 (1999) 412-419
19. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res 49 (1989) 4682-4689
20. Moscow J.A., He R., Gnarra J.R., et al. Examination of human tumors for rhoA mutations. Oncogene 9 (1994) 189-194
21. Boivin D., Bilodeau D., and Beliveau R. Regulation of cytoskeletal functions by Rho small GTP-binding proteins in normal and cancer cells. Can J Physiol Pharmacol 74 (1996) 801-810
22. Crespo P., Schuebel K.E., Ostrom A.A., Gutkind J.S., and Bustelo X.R. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385 (1997) 169-172
23. Eva A., and Aaronson S.A. Isolation of a new human oncogene from a diffuse B-cell lymphoma. Nature 316 (1985) 273-275
24. Habets G.G., Scholtes E.H., Zuydgeest D., et al. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77 (1994) 537-549
25. Aznar S., Fernandez-Valeron P., Espina C., et al. Rho GTPases: potential candidates for anticancer therapy. Cancer Lett 206 (2004) 181-191
26. Banyard J., Anand-Apte B., Symons M., et al. Motility and invasion are differentially modulated by Rho family GTPases. Oncogene 19 (2000) 580-591
27. Jaffe A.B., and Hall A. Rho GTPases in transformation and metastasis. Adv Cancer Res 84 (2002) 57-80
28. Lin M., and van Golen K.L. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat 84 (2004) 49-60
29. Rosenfeld C., Goutner A., Choquet C., et al. Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 267 (1977) 841-843
30. Uphoff C.C., MacLeod R.A., Denkmann S.A., et al. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. Leukemia 11 (1997) 441-447
31. Morikawa S., Tatsumi E., Baba M., Harada T., and Yasuhira K. Two E-rosette-forming lymphoid cell lines. Int J Cancer 21 (1978) 166-170
32. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, New York
33. Hall P.A., Levison D.A., Woods A.L., et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162 (1990) 285-294
34. Ren X.D., Kiosses W.B., and Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 18 (1999) 578-585
35. Reid T., Furuyashiki T., Ishizaki T., et al. Rhotekin, a putative target for Rho bearing homology to a serine/threonine kinase, PKN and Rhophilin in the Rho binding domain. J Biol Chem 271 (1996) 13556-13560
36. Gosser Y.Q., Nomanbhoy T.K., Aghazadeh B., et al. C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature 387 (1997) 814-819
37. Biou V., Gibrat J.F., Levin J.M., Robson B., and Garnier J. Secondary structure prediction: combination of three different methods. Protein Eng 2 (1988) 185-191
38. Hordijk P.L., ten Klooster J.P., Van der Kammen R.A., Michiels F., Oomen L.C.J.M., and Collard J.G. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 278 (1997) 1464-1466
39. Hotchin N.A., and Hall A. The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J Cell Biol 131 (1995) 1857-1865
40. Tokman M.G., Porter R.A., and Williams C.L. Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Res 57 (1997) 1785-1793
41. Itoh K., Yoshioka K., Akedo H., Uehata M., Ishizaki T., and Narumiya S. An essential part Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 5 (1999) 221-225
42. Hirao M., Sato N., Kondo T., et al. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 135 (1996) 37-51
43. Zhang Y., and Zhang B. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 66 (2006) 5592-5598
44. Ishizaki H., Togawa A., Tanaka-Okamoto M., et al. Defective chemokine-directed lymphocyte migration and development in the absence of rho guanosine diphosphate-dissociation inhibitors alpha and beta. J Immunol 177 (2006) 8512-8521
45. Danley D.E., Chuang T.H., and Bokoch G.M. Defective Rho GTPase regulation by IL-1 beta-converting enzyme-mediated cleavage of D4 GDP dissociation inhibitor. J Immunol 157 (1996) 500-503
46. Rickers A., Brockstedt E., Mapara M.Y., Otto A., Dorken B., and Bommert K. Inhibition of CPP32 blocks surface IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt lymphoma cells. Eur J Immunol 28 (1998) 296-304
47. Yin L., Schwartzberg P., Scharton-Kersten T.M., Staudt L., and Lenardo M. Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases. Mol Immunol 34 (1997) 481-491
48. Guillemot J.-C., Kruskal B.A., Adra C.N., et al. Targeted disruption of guanosine diiphosphate-dissociation inhibitor for Rho-related protein, GDID4: normal hematopoietic differentiation but subtle defect in superoxide production by macrophages derived from in vitro embryonal stem cell differentiation. Blood 88 (1996) 2722-2731
49. Li S., Ross D.T., Kadin M.E., Brown P.O., and Wasik M.A. Comparative genome-scale analysis of gene expression profiles in t cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol 158 (2001) 1231-1237
50. Tapper J., Kettunen E., El Rifai W., et al. Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 128 (2001) 1-6
51. Gildea J.J., Seraj M.J., Oxford G., et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62 (2002) 6418-6423
52. Theodorescu D., Sapinoso L.M., Conaway M.R., et al. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10 (2004) 3800-3806